http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#Head http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#assertion http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#provenance http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#pubinfo http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#assertion http://purl.obolibrary.org/obo/MONDO_0001156 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0001156 http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB00334 http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association http://www.w3.org/2000/01/rdf-schema#label Antipsychotics have been found to reduce BPD symptoms including aripiprazole (mean daily dose: 15 mg); ziprasidone (mean daily dose: 20 to 80 mg), olanzapine (mean daily dose: 5 to 9 mg, daily dose range 5 to 20 mg), haloperidol (mean daily dose 5 mg, daily dose range 4 to 16 mg), Quetiapine XL (at a daily dose of 150 mg). The empirically use of antipsychotics in patients with BPD are considered as off-label use. http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#cohort http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28825781/ http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#cohort http://www.w3.org/2000/01/rdf-schema#label Adults http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort https://go.drugbank.com/drugs/DB00334 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#provenance http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#pubinfo http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig http://purl.org/nanopub/x/hasSignature brKON5IvjKt8Rl0LVnjpdLlRh+8G8Qs9R/rKY/+DxfzyON8HyVhEr2TP7nVwoJzhJVL/77+37mjz2qRkOKmJkD+Que8eigUrxSlBekABAx7/PIf3nzWjBNalmZpIy9R6fETb9SQZyZu/pEiAjm0wOrWyqPElxmakFS3ikUYSTd0= http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU http://purl.org/dc/terms/created 2021-05-28T22:37:01.486+02:00 http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAIt_A_buQVyeebYsDayx4xKovDxqK3IQJgdIeo2j_CaU https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs